2013
DOI: 10.1093/carcin/bgt054
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models

Abstract: As the conventional approach to assess the potential of a chemical to cause cancer in humans still includes the 2-year rodent carcinogenicity bioassay, development of alternative methodologies is needed. In the present study, the transcriptomics responses following exposure to genotoxic (GTX) and non-genotoxic (NGTX) hepatocarcinogens and non-carcinogens (NC) in five liver-based in vitro models, namely conventional and epigenetically stabilized cultures of primary rat hepatocytes, the human hepatoma-derived ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
42
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 48 publications
(43 citation statements)
references
References 36 publications
1
42
0
Order By: Relevance
“…Since the liver represents one of the major target organs in the rodent cancer bioassay, a human liver cell model thus is a preferred option. In toxicogenomics, HepG2 has previously been shown to provide a model for classifying carcinogenic chemicals with higher accuracy that the rodent cancer bioassay (19,20). While this has been the outcome of statistical approaches, it is now tempting to also subject the HepG2 cell system to mechanistic investigations, using high throughput sequencing.…”
Section: Resultsmentioning
confidence: 99%
“…Since the liver represents one of the major target organs in the rodent cancer bioassay, a human liver cell model thus is a preferred option. In toxicogenomics, HepG2 has previously been shown to provide a model for classifying carcinogenic chemicals with higher accuracy that the rodent cancer bioassay (19,20). While this has been the outcome of statistical approaches, it is now tempting to also subject the HepG2 cell system to mechanistic investigations, using high throughput sequencing.…”
Section: Resultsmentioning
confidence: 99%
“…In a study by Doktorova et al [2013], human hepatoma‐dervied HepaRG cells were exposed to 15 prototypical compounds belonging to three toxic classes: (i) genotoxic carcinogens [AFB1; 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK); 2‐nitrofluorene (2NF); BaP; cyclophosphamide (CYCLO)], (ii) nongenotoxic carcinogens [methapyrilene hydrochloride (MPH); piperonylbutoxide (PIPB), Wy‐14643 (WYE), phenobarbital sodium (SPB), 12‐ O ‐tetradecanoylphorbol‐13‐acetate (TPA)]; and (iii) noncarcinogens [nifedipine (NIF); clonidine (CND); d ‐mannitol (MAN); tolbutamide (TOL); diclofenac sodium (SDF)] for 72 hr to study the transcriptomic responses. Raw CEL files from this study generated using Affymetrix U133 Plus 2.0 GeneChips (GEO accession number GSE40117) were downloaded to test the TGx‐28.65 biomaker in a human cell line with inherent metabolic capabilities [Doktorova et al, ]. The human HepaRG microarray data were RMA normalized in R using the ReadAffy function in the Affy package.…”
Section: Methodsmentioning
confidence: 99%
“…Especially the AB1 datasets with the identifiers x and y from Tryndyak et al () (cp. Table ) and the NNK data from Doktorova et al () were different from the other datasets in the PCA analysis. Results were similar when only the DEGs were considered for the PCA instead of the entire datasets (not shown).…”
Section: Resultsmentioning
confidence: 74%